Interleukin‐6‐mediated resistance to immunotherapy is linked to impaired myeloid cell function
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin‐6‐mediated resistance to immunotherapy is linked to impaired myeloid cell function
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-02
DOI
10.1002/ijc.33280
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Strong vaccine responses during chemotherapy are associated with prolonged cancer survival
- (2020) Cornelis J. M. Melief et al. Science Translational Medicine
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Frontline Science: Proliferation of Ly6C + monocytes during urinary tract infections is regulated by IL-6 trans-signaling
- (2017) Akanksha Dixit et al. JOURNAL OF LEUKOCYTE BIOLOGY
- IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4+ T cells
- (2016) Yosuke Ohno et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement
- (2016) Rashmi Bharti et al. CANCER LETTERS
- Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses
- (2016) Marij J. Welters et al. Science Translational Medicine
- Tumor microenvironment: Sanctuary of the devil
- (2015) Lanlan Hui et al. CANCER LETTERS
- Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma
- (2015) TEPPEI JINNO et al. ONCOLOGY REPORTS
- Vaccine-induced tumor regression requires a dynamic cooperation between T cells and myeloid cells at the tumor site
- (2015) Maxime Thoreau et al. Oncotarget
- Therapeutic Peptide Vaccine-Induced CD8 T Cells Strongly Modulate Intratumoral Macrophages Required for Tumor Regression
- (2015) T. C. van der Sluis et al. Cancer Immunology Research
- IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
- (2014) Koji Taniguchi et al. SEMINARS IN IMMUNOLOGY
- Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment
- (2013) E. M. Dijkgraaf et al. CANCER RESEARCH
- Soluble interleukin-6 receptor is a serum biomarker for the response of esophageal carcinoma to neoadjuvant chemoradiotherapy
- (2013) Yosuke Makuuchi et al. CANCER SCIENCE
- Cervical cancer cell-derived interleukin-6 impairs CCR7-dependent migration of MMP-9-expressing dendritic cells
- (2013) Jennifer Pahne-Zeppenfeld et al. INTERNATIONAL JOURNAL OF CANCER
- Cytokine patterns in patients with cancer: a systematic review
- (2013) Bodo E Lippitz LANCET ONCOLOGY
- Interleukin-6 signaling pathway in targeted therapy for cancer
- (2012) Yuqi Guo et al. CANCER TREATMENT REVIEWS
- Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer
- (2012) Eveline M. Dijkgraaf et al. CURRENT PHARMACEUTICAL DESIGN
- The role of interleukin-6 in gynaecological malignancies
- (2012) Jermaine I.G. Coward et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2
- (2012) Sharon Cohen et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- M2 Macrophages Induced by Prostaglandin E2 and IL-6 from Cervical Carcinoma Are Switched to Activated M1 Macrophages by CD4+ Th1 Cells
- (2011) M. Heusinkveld et al. JOURNAL OF IMMUNOLOGY
- Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells
- (2010) Yue Wang et al. CANCER LETTERS
- Effects of Siltuximab on the IL-6-Induced Signaling Pathway in Ovarian Cancer
- (2010) Y. Guo et al. CLINICAL CANCER RESEARCH
- gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
- (2009) Julia Bollrath et al. CANCER CELL
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- CCL2 and Interleukin-6 Promote Survival of Human CD11b+Peripheral Blood Mononuclear Cells and Induce M2-type Macrophage Polarization
- (2009) Hernan Roca et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Constitutive activation of signal transducer and activator of transcription 3 in epithelial ovarian carcinoma
- (2009) Hao Min et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- The value of tumor marker and cytokine analysis for the assessment of regional lymph node status in cervical cancer patients
- (2008) B. KOTOWICZ et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now